Back to User profile » Dr Yu-Bo Xie
Papers published by Dr Yu-Bo Xie:
Comparison of the Effects of Combined Femoral and Sciatic Nerves Block versus General Anesthesia on Hemodynamic Stability and Postoperative Complication in Patients with Diabetic Foot: A Prospective, Double-Blind and Randomized Controlled Trial
Zou L, Wei Q, Pan S, Xiao F, Jiang Y, Zhong Y, Xie Y
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2243-2257
Published Date: 5 June 2024
The Influencing Factors of Frailty and Quality of Life in Elderly Patients After Spinal Surgery
Gong Z, Su F, Kang X, Zhong Y, Xie Y
Clinical Interventions in Aging 2024, 19:769-778
Published Date: 9 May 2024
Association Between Preoperative Sleep Disturbance and Postoperative Delirium in Elderly: A Retrospective Cohort Study
Guo H, Li LH, Lv XH, Su FZ, Chen J, Xiao F, Shi M, Xie YB
Nature and Science of Sleep 2024, 16:389-400
Published Date: 16 April 2024
The Safety and Efficacy of Remimazolam Compared to Dexmedetomidine for Awake Tracheal Intubation by Flexible Bronchoscopy: A Randomized, Double-Blind, Controlled Trial
Chen Q, Qin B, Zhang M, Zhou Y, Shi X, Xie Y
Drug Design, Development and Therapy 2024, 18:967-978
Published Date: 28 March 2024
Ultrasonographic Assessment of Gastric Volume in Fasted Patients Undergoing Gastrointestinal Endoscopy Under Sedation
Rong H, Dai W, Qin Y, Meng Z, Zou X, Wang B, Wei Q, Xie Y
Therapeutics and Clinical Risk Management 2023, 19:685-698
Published Date: 23 August 2023
Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro
Liang B, Li C, Zhou Z, Xie Y
Drug Design, Development and Therapy 2023, 17:1037-1045
Published Date: 6 April 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis
Shi M, Chen J, Liu T, Dai W, Zhou Z, Chen L, Xie Y
Drug Design, Development and Therapy 2022, 16:413-423
Published Date: 18 February 2022
High-Dose Dexmedetomidine Promotes Apoptosis in Fetal Rat Hippocampal Neurons
Wei Q, Chen J, Xiao F, Tu Y, Zhong Y, Xie Y
Drug Design, Development and Therapy 2021, 15:2433-2444
Published Date: 8 June 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dexmedetomidine attenuates the neurotoxicity of propofol toward primary hippocampal neurons in vitro via Erk1/2/CREB/BDNF signaling pathways
Tu Y, Liang Y, Xiao Y, Lv J, Guan R, Xiao F, Xie Y, Xiao Q
Drug Design, Development and Therapy 2019, 13:695-706
Published Date: 19 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
Xiao Y, Zhou L, Tu Y, Li Y, Liang Y, Zhang X, Lv J, Zhong Y, Xie Y
Neuropsychiatric Disease and Treatment 2018, 14:2191-2206
Published Date: 28 August 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2–STAT3 pathway
Chen Y, Zhang X, Zhang B, He G, Zhou L, Xie Y
Drug Design, Development and Therapy 2017, 11:2787-2799
Published Date: 26 September 2017